Fibroblast Growth Factor 2 Internal Ribosome Entry Site (Ires) Activity Ex Vivo and in Transgenic Mice Reveals a Stringent Tissue-Specific Regulation

by Créancier, Laurent, Morello, Dominique, Mercier, Pascale, Prats, Anne-Catherine
Published 2000

Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors

by Douin, Victorine, Bornes, Stephanie, Creancier, Laurent, Rochaix, Philippe, Favre, Gilles, Prats, Anne-Catherine, Couderc, Bettina
Published 2004

Optical Imaging of Disseminated Leukemia Models in Mice with Near-Infrared Probe Conjugated to a Monoclonal Antibody

by Pesnel, Sabrina, Pillon, Arnaud, Créancier, Laurent, Lerondel, Stéphanie, Le Pape, Alain, Recher, Christian, Demur, Cécile, Guilbaud, Nicolas, Kruczynski, Anna
Published 2012

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

by LaRochelle, Olivier, Bertoli, Sarah, Vergez, François, Sarry, Jean-Emmanuel, Mansat-De Mas, Véronique, Dobbelstein, Sophie, Dastugue, Nicole, Strzelecki, Anne-Claire, Cavelier, Cindy, Creancier, Laurent, Pillon, Arnaud, Kruczynski, Anna, Demur, Cécile, Sarry, Audrey, Huguet, Françoise, Huynh, Anne, Récher, Christian, Delabesse, Eric
Published 2011